These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8075860)
1. Comparison of the ability of nicardipine, theophylline and zaprinast to restore cardiovascular haemodynamics following inhibition of nitric oxide synthesis. Herity NA; Allen JD; Silke B; Adgey AA Br J Pharmacol; 1994 Jun; 112(2):423-8. PubMed ID: 8075860 [TBL] [Abstract][Full Text] [Related]
2. Assessment of ability of levcromakalim and sodium nitroprusside to reverse the cardiovascular effects of nitric oxide synthase inhibition in the anaesthetised pig. Herity NA; Allen JD; Silke B; Adgey AA Cardiovasc Res; 1994 Jun; 28(6):894-900. PubMed ID: 7522965 [TBL] [Abstract][Full Text] [Related]
3. Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. McMahon TJ; Ignarro LJ; Kadowitz PJ J Appl Physiol (1985); 1993 Apr; 74(4):1704-11. PubMed ID: 8390441 [TBL] [Abstract][Full Text] [Related]
5. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. Anderson IK; Drew GM Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286 [TBL] [Abstract][Full Text] [Related]
6. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats. Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904 [TBL] [Abstract][Full Text] [Related]
7. L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs. Alemayehu A; Lock KR; Coatney RW; Chou CC Br J Pharmacol; 1994 Jan; 111(1):205-12. PubMed ID: 8012697 [TBL] [Abstract][Full Text] [Related]
8. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Thusu KG; Morin FC; Russell JA; Steinhorn RH Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302 [TBL] [Abstract][Full Text] [Related]
9. The effects of N omega-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat. Bower EA; Law AC Br J Pharmacol; 1993 Apr; 108(4):933-40. PubMed ID: 8485632 [TBL] [Abstract][Full Text] [Related]
10. Effects of phosphodiesterase inhibitors on hypoxic pulmonary vasoconstriction. Influence of K(+) channels and nitric oxide. Goirand F; Bardou M; Dumas J; Rochette L; Dumas M Eur J Pharmacol; 2001 Apr; 417(1-2):141-8. PubMed ID: 11301069 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of pressor and haemodynamic effects of NG-nitro-L-arginine by halothane. Wang YX; Abdelrahman A; Pang CC J Cardiovasc Pharmacol; 1993 Oct; 22(4):571-8. PubMed ID: 7505359 [TBL] [Abstract][Full Text] [Related]
12. Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia. Cohen RI; Shapir Y; Chen L; Scharf SM Crit Care Med; 1998 Apr; 26(4):738-47. PubMed ID: 9559613 [TBL] [Abstract][Full Text] [Related]
13. L-Arginine, a precursor of EDRF in vitro, produces pulmonary vasodilation in lambs. Fineman JR; Chang R; Soifer SJ Am J Physiol; 1991 Nov; 261(5 Pt 2):H1563-9. PubMed ID: 1659228 [TBL] [Abstract][Full Text] [Related]
14. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast. Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042 [TBL] [Abstract][Full Text] [Related]
15. Overall hemodynamic studies after the chronic inhibition of endothelial-derived nitric oxide in rats. Huang M; Manning RD; LeBlanc MH; Hester RL Am J Hypertens; 1995 Apr; 8(4 Pt 1):358-64. PubMed ID: 7619348 [TBL] [Abstract][Full Text] [Related]
16. NG-nitro L-arginine methyl ester: systemic and pulmonary haemodynamics, tissue blood flow and arteriovenous shunting in the pig. van Gelderen EM; Den Boer MO; Saxena PR Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):417-23. PubMed ID: 8277978 [TBL] [Abstract][Full Text] [Related]
17. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH Am J Physiol; 1995 Aug; 269(2 Pt 2):H473-9. PubMed ID: 7653611 [TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Liu SF; Crawley DE; Rohde JA; Evans TW; Barnes PJ Br J Pharmacol; 1992 Nov; 107(3):861-6. PubMed ID: 1335345 [TBL] [Abstract][Full Text] [Related]
19. Zaprinast, a type V phosphodiesterase inhibitor, dilates capacitance vessels in anaesthetised rats. Ng SS; Pang CC Eur J Pharmacol; 1998 Jun; 351(3):323-8. PubMed ID: 9721024 [TBL] [Abstract][Full Text] [Related]
20. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Weiss HR; Rodriguez E; Tse J; Scholz PM Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]